The integration of artificial intelligence (AI) into healthcare systems has revolutionized clinical analytics, enabling enhanced diagnostic accuracy, predictive modeling, and personalized treatment pathways. However, the opacity of many AI models poses significant challenges to their clinical adoption, necessitating advancements in explainable AI (XAI) to ensure interpretability and transparency. This narrative review synthesizes the literature on XAI within clinical systems, focusing on interpretability mechanisms, transparency frameworks, and deployment constraints in healthcare analytics. Drawing from high-impact studies, we examine how XAI addresses the “black box” nature of machine learning models in high-stakes medical decisions, particularly in contexts where performance has traditionally been prioritized over explainability. Key themes include the shift toward inherently interpretable models for critical applications, such as diagnostic imaging and predictive analytics, where post-hoc explanations often fall short. We explore the ethical imperatives for responsible AI deployment, including strategies for mitigating harm through transparent systems that align with clinical workflows. The review integrates perspectives on XAI in clinical diagnostics, emphasizing challenges in balancing model complexity with user trust. Transparency is framed not merely as a technical feature but as a systemic requirement, incorporating structured reporting practices for AI interventions and standardized modeling approaches. Deployment constraints are analyzed through the lens of real-world integration, including regulatory considerations, data privacy concerns, and human–AI interaction dynamics in healthcare infrastructures. We synthesize evidence from diverse applications, such as lung cancer diagnosis via explainable models and radiographic assessments, underscoring the need for multidisciplinary approaches to XAI. Furthermore, the review highlights biases in AI systems, particularly sex and gender disparities, and advocates for inclusive analytics to foster equitable healthcare. Clinical applications beyond the black box are discussed, with calls for standardized reporting to enhance reproducibility and trust. We position XAI as essential for closed-loop systems that incorporate feedback mechanisms, ensuring ongoing model recalibration in dynamic clinical environments. The synthesis reveals persistent gaps in current XAI deployments, such as overreliance on surrogate explanations that may mislead clinicians. Ultimately, this review proposes a systems-level framework for XAI in healthcare, integrating data ingestion, inference, decision support, and governance loops to overcome transparency barriers. This comprehensive overview informs the development of future AI-enabled healthcare infrastructures, emphasizing interpretability as a cornerstone for safe and effective clinical analytics.
The integration of artificial intelligence (AI) into healthcare systems has transformed population health analytics, enabling scalable infrastructures that process vast datasets to inform clinical decisions, resource allocation, and policy-making. This narrative review synthesizes recent literature on AI system architectures and governance models, focusing on how these elements underpin analytics-driven healthcare ecosystems. We examine the evolution of AI-enabled infrastructures, emphasizing federated learning, explainable models, and ethical frameworks to address data privacy, interoperability, and equity in population-level analytics. Key architectures include vertically integrated systems that streamline data ingestion, model deployment, and real-time inference, as seen in federated approaches that mitigate data silos while preserving patient confidentiality. Governance models are critical for ensuring trustworthy AI deployment, incorporating regulatory oversight, ethical principles adapted from military contexts to healthcare, and consensus-based guidelines for prediction models. We highlight the role of blockchain and data trusts in enhancing transparency and consent mechanisms, particularly in global health responses to pandemics and chronic disease management. The review structures the discourse around systems-level framing, integrating data flows, algorithmic decision support, and closed-loop feedback mechanisms that adapt to clinical outcomes. For instance, electronic health record (EHR)-based prediction models facilitate acute illness forecasting and outcome prediction in conditions like rheumatoid arthritis and oncology. We propose an original synthesis logic that conceptualizes AI infrastructures as adaptive networks, where governance acts as a regulatory layer overlaying architectural components to balance innovation with risk mitigation. Challenges such as bias in commercial datasets and the need for international cooperation are noted, but the emphasis remains on infrastructural resilience. Ultimately, this synthesis underscores the imperative for hybrid human-AI systems that prioritize population health equity, with governance models evolving to support sustainable analytics infrastructures. By positioning AI as a foundational tool for healthcare transformation, the review advocates for interdisciplinary collaboration to refine these systems, ensuring they deliver actionable insights while upholding ethical standards in diverse healthcare settings.
Generative artificial intelligence (GenAI) has emerged as a transformative force in healthcare systems, enabling advanced analytics, personalized interventions, and streamlined governance frameworks. This narrative review synthesizes recent literature on GenAI’s integration into healthcare infrastructures, emphasizing systems governance, safety protocols, and accountability mechanisms. We explore how GenAI enhances clinical decision-making, data analytics, and closed-loop systems while addressing ethical, regulatory, and operational challenges.At the core of healthcare systems, GenAI facilitates intelligent analytics by generating synthetic data for training models, simulating patient outcomes, and optimizing resource allocation. Governance frameworks are critical for ensuring responsible deployment, with studies highlighting the need for institutional guidelines that mitigate risks such as bias amplification and data privacy breaches. Safety considerations encompass algorithmic transparency, error detection in generative outputs, and human oversight in clinical loops. Accountability extends to lifecycle management, from model development to post-deployment monitoring, as evidenced by global initiatives and regional models like those in the GCC.The review delineates the landscape of GenAI applications in healthcare analytics, including predictive modeling for chronic disease management and real-time decision support. We propose an original systems-level framing that integrates data ingestion, inference generation, intervention deployment, and feedback recalibration under governance umbrellas. This synthesis reveals gaps in current infrastructures, such as the lack of standardized AI guardians for information overload and the challenges of scaling enterprise AI.In examining intelligent clinical decision systems, we highlight architectures that fuse GenAI with electronic health records (EHRs) for closed-loop operations, where generative models inform adaptive interventions. Ethical considerations are woven throughout, advocating for principles adapted from military contexts to healthcare. The adoption of GenAI in US hospitals underscores its potential for inpatient summaries and chronic care, yet calls for regulatory oversight to align with Helsinki declarations.Ultimately, this review positions GenAI as a cornerstone for accountable healthcare systems, urging interdisciplinary collaboration to balance innovation with safety. By synthesizing governance models, safety protocols, and accountability structures, we provide a roadmap for sustainable integration, fostering equitable health outcomes in an AI-augmented era.
The integration of artificial intelligence (AI) into healthcare systems has revolutionized clinical analytics, enabling predictive modeling, diagnostic support, and personalized interventions. However, the post-deployment phase of these AI systems presents unique challenges, particularly in maintaining performance amid evolving clinical environments. This narrative review synthesizes recent literature on post-deployment monitoring strategies for clinical AI, focusing on drift detection, feedback governance, and update policies within healthcare systems and analytics frameworks. We examine how data shifts—arising from changes in patient demographics, clinical protocols, or external factors—can degrade AI model efficacy, leading to suboptimal outcomes in high-stakes settings like disease prediction and resource allocation. Drift detection emerges as a cornerstone, encompassing statistical methods to identify concept drift, covariate shift, and label drift in real-time healthcare data streams. Techniques such as nonparametric monitoring and ensemble-based approaches allow for proactive identification of performance decay, ensuring AI systems remain aligned with dynamic clinical realities. Feedback governance integrates human-in-the-loop mechanisms, where clinician inputs refine AI outputs, fostering trust and regulatory compliance in governance structures. Update policies, including retraining schedules and federated learning paradigms, to address the need for iterative model evolution without disrupting clinical workflows. We highlight systems-level perspectives, such as closed-loop architectures that link monitoring to automated updates, emphasizing interoperability across electronic health records (EHRs) and AI pipelines. Comparative analysis reveals gaps in current practices, including limited scalability in resource-constrained settings and ethical considerations in data privacy during monitoring. Through an original synthesis, we propose an integrative framework for AI lifecycle management in healthcare, underscoring the interplay between drift metrics, governance protocols, and policy-driven updates to enhance patient safety and system resilience. This review underscores the imperative for standardized monitoring protocols, informed by multidisciplinary insights, to bridge the translational gap from AI development to sustained clinical utility. By addressing these elements, healthcare AI can achieve robust, adaptive performance, ultimately improving analytics-driven decision-making and outcomes in diverse clinical contexts. Future directions include harmonizing international guidelines for AI monitoring, integrating explainable AI for better feedback loops, and leveraging emerging technologies like edge computing for real-time drift management. This synthesis provides a foundation for researchers and practitioners to advance post-deployment strategies, ensuring AI’s enduring impact on healthcare systems.
The rapid evolution of artificial intelligence in healthcare has spotlighted the need for reliable home monitoring systems to verify patient adherence to prescribed regimens. This conceptual manuscript introduces a novel framework for adherence verification leveraging passive signals—such as ambient sensors, wearables, and environmental data—while robustly addressing data missingness. Traditional approaches often falter in real-world deployments due to intermittent signal capture, leading to inaccurate assessments and compromised clinical decisions. We propose the missingness-resilient adherence orchestration network (MRAON), an architectural construct that integrates multi-modal passive signals through layered processing, incorporating missingness-informed imputation strategies and adaptive detection mechanisms. The framework emphasizes theoretical infrastructure for signal fusion, risk propagation modeling, and governance of decision confidence under uncertainty. By synthesizing recent literature on passive monitoring and missing data handling, we delineate how MRAON enhances verification robustness without relying on empirical evaluations. Key conceptual formulas capture dynamics like decision confidence as a function of missingness severity and monitoring burden influenced by resource allocation. This work advances theoretical discourse in AI-driven healthcare analytics, offering a blueprint for scalable, ethical home monitoring systems that prioritize patient autonomy and data integrity. Ultimately, MRAON paves the way for future integrations in chronic disease management, reducing healthcare burdens through intelligent, passive adherence detection.
Alzheimer’s disease (AD) is the leading cause of dementia, affecting over 50 million people worldwide, with prevalence expected to triple by 2050. Early detection is crucial for clinical trial enrollment and care planning, and multimodal data (MRI, PET, CSF biomarkers, and cognitive assessments) provides complementary information on neurodegeneration, metabolism, and protein aggregation. This systematic review synthesizes AI/ML approaches for early AD detection using multimodal data, focusing on fusion strategies and performance across disease stages. Following PRISMA guidelines, searches of PubMed, IEEE Xplore, Scopus, Web of Science, and arXiv (2017–2023) identified studies using ML/DL with at least two modalities and reporting diagnostic performance. From 1,247 records, 35 studies were included. MRI was the most used modality (>90%), followed by cognitive tests (70–80%), PET (40–50%), and CSF (20–30%). Early fusion was most common, with increasing use of intermediate fusion. Multimodal models achieved AUROC of 0.90–0.98 for AD vs controls, but lower performance (0.70–0.85) for predicting MCI conversion to AD. Overall, multimodal AI improves early AD detection, with strong performance for diagnosis but persistent challenges in forecasting MCI progression due to heterogeneity and limited longitudinal data.
The integration of artificial intelligence into clinical decision support systems offers improved diagnostic accuracy and efficiency, but the opacity of many machine learning models raises concerns about trust, accountability, and regulatory compliance. Explainable artificial intelligence (XAI) has been proposed to address this by making model predictions interpretable to clinicians; however, its true clinical value remains uncertain, and evaluation has not kept pace with methodological development. This systematic review aimed to identify XAI methods used in clinical decision support systems, assess how they are evaluated with clinicians, and determine whether explanations improve diagnostic accuracy, trust, mental models, and efficiency. Following PRISMA guidelines, we searched PubMed, Web of Science, IEEE Xplore, ACM Digital Library, and Scopus for studies published between 2017 and 2024. Eligible studies included original research evaluating XAI in clinical decision support systems with clinician participants and reporting quantitative or qualitative outcomes. Risk of bias was assessed using adapted QUADAS-2 and ROBIS tools, and findings were synthesized narratively with subgroup analyses. From 2,847 records, 68 studies were included. The most common XAI methods were SHAP-based feature attribution (38%), saliency or heatmap methods (29%), concept-based approaches such as TCAV (15%), and counterfactual or example-based explanations (12%). Radiology was the dominant field (54%), followed by dermatology (18%) and pathology (12%). Evaluation approaches were highly inconsistent, with few validated instruments and most studies relying on Likert-scale trust measures or qualitative feedback. Only 16% of studies showed improved diagnostic accuracy with explanations, 67% showed no significant effect, and 17% reported reduced accuracy due to over-reliance or misinterpretation. Although 82% of studies reported increased clinician trust, trust rarely correlated with actual diagnostic performance. Overall, while XAI methods are widely studied in clinical decision support, their evaluation is inconsistent and their benefits are limited. Explanations tend to increase clinician trust without reliably improving diagnostic accuracy, and may sometimes worsen performance, highlighting a trust–accuracy gap that poses important safety concerns for clinical deployment.
Clinical documentation is central to continuity of care, coding, billing, compliance, and quality measurement, yet it remains a major source of administrative burden for physicians. Artificial intelligence, especially natural language processing, has been proposed as a way to improve documentation quality, coding accuracy, billing support, and clinical workflow efficiency. This systematic review synthesised evidence from 2017 to 2023 on natural language processing methods applied to clinical documentation improvement. The review focused on automated clinical coding, note quality, billing support, computer-assisted physician documentation, and physician workflow efficiency. A PRISMA 2020-compliant search strategy was applied to PubMed, Scopus, IEEE Xplore, and Web of Science for publications from 1 January 2017 to 31 December 2023. Screening was performed in duplicate, and eligible studies were narratively synthesised by documentation domain, model type, deployment maturity, and evaluation approach. The evidence base expanded rapidly during the review period, especially in automated coding and clinical note generation. Several studies reported technically promising systems for ICD coding, documentation summarisation, and speech-derived notes, whereas billing outcomes and sustained workflow effects were less commonly evaluated. Natural language processing for clinical documentation improvement appears most mature for automated coding and note analysis. Evidence for billing support and physician workflow transformation remains less developed, particularly in prospective clinical environments.
Smart hospitals increasingly combine artificial intelligence, real-time data streams, operational dashboards, and automated decision support to coordinate care delivery. These systems aim to improve hospital throughput, staff efficiency, resource use, and patient safety. This systematic review synthesised evidence on AI technologies used in smart hospital management from 2017 to 2023. The review focused on command centers, real-time workflow monitoring, operational dashboards, and automated decision support systems. A PRISMA 2020-compliant review process was used, including structured database searching, dual screening, and narrative synthesis. Extracted data covered study characteristics, AI methods, deployment maturity, data sources, integration patterns, and reported operational impact. The evidence base was concentrated on hospital command centers, predictive dashboards, and patient-flow analytics. Real-time workflow monitoring and automated decision support were less mature, and prospective evaluations of operational or clinical impact were uncommon. AI-enabled smart hospital management is technologically promising but remains unevenly implemented and weakly evaluated. Current evidence supports cautious adoption, local validation, and stronger evaluation designs before claims of sustained operational transformation are accepted.
Specialty referral pathways are a critical point at which healthcare inequities can emerge. Referral decisions may be shaped by insurance status, race, language, documentation practices, diagnosis severity, and the structure of available provider networks. Health systems often lack scalable and explainable tools for detecting inequitable referral patterns as they occur. As a result, discriminatory or structurally biased patterns may remain hidden within routine clinical operations. This article develops a conceptual explainable artificial intelligence model for identifying whether demographic or insurance factors unduly influence specialty referral decisions after accounting for clinical severity. The model is designed to support transparent, fairness-oriented referral analytics rather than replace clinical judgment. The proposed model uses a gradient-boosted classification framework trained on referral-eligible primary care encounters. Input features include patient demographics, insurance type, diagnosis severity, primary care note-derived complexity and completeness features, and provider network metrics, with SHAP-based explanation layers used for fairness auditing. Conceptually, the model could flag encounters in which predicted referral likelihood diverges from clinically expected patterns. These flags would be interpreted through explanation methods that attribute potential inequitable influence to insurance, demographic, documentation, or network-related factors. The model could help health systems audit, explain, and intervene on systemic specialty referral bias. Its central contribution is a transparent framework for moving referral equity work from retrospective description toward proactive, data-driven fairness review.
Medical equipment shortages and surpluses often coexist in hospitals because utilization is observed after demand has already emerged rather than predicted in advance. Expensive mobile assets may sit idle in low-demand areas while clinicians search for pumps, monitors, beds, ventilators, or imaging-related devices in high-demand units. Current equipment management often depends on manual counts, static par levels, delayed inventory review, and reactive dispatching. These practices do not fully integrate forward-looking signals already present in procedure schedules, unit demand projections, maintenance logs, and device availability records. This article proposes an artificial intelligence framework that ingests real-time location system data, procedure schedules, maintenance logs, unit-level demand forecasts, and device availability records. The framework is designed to generate continuous predictions of equipment utilization and impending shortages across hospital units. The framework includes a real-time location ingestion module, a procedure-schedule demand mapper, a maintenance downtime predictor, a unit-level demand forecaster, a multi-source fusion engine, and an operational decision-support dashboard. These components would convert fragmented hospital data streams into coordinated predictions for equipment planning. The framework would shift equipment management from reactive searching toward proactive allocation. It would be expected to reduce avoidable idle time, improve visibility of available equipment pools, and support earlier decisions about staging, redistribution, maintenance rescheduling, or rental planning. An AI-enabled equipment utilization framework offers a pathway toward a data-driven and anticipatory medical equipment supply chain. Such a framework could help hospitals coordinate scarce assets more effectively in complex, high-pressure clinical environments.
Home health agencies must assign clinicians to patients across geographically dispersed service areas while balancing patient needs, workforce qualifications, and operational efficiency. Scheduling decisions must account for clinical urgency, visit complexity, travel burden, and continuity of care. Manual scheduling cannot reliably integrate real-time acuity changes, dynamic travel conditions, clinician availability, and the risk of patients refusing or missing care. As a result, agencies may experience avoidable inefficiencies, delayed visits, fragmented follow-up, and increased coordinator workload. This article proposes an AI-based home health scheduling system that integrates patient acuity, geographic routing, clinician skill profiles, visit duration estimates, and missed-care risk prediction. The system is designed to generate adaptive daily schedules that can be revised as clinical and operational conditions change. The framework includes a patient acuity classifier, visit duration estimator, geographic routing engine, skill-mix matcher, missed-care risk predictor, and real-time scheduling dashboard. These components operate together to support clinically appropriate, geographically efficient, and operationally feasible visit plans. The proposed system would be expected to improve scheduling responsiveness, reduce unnecessary travel, better align clinician competencies with patient needs, and support proactive follow-up for patients at risk of missed care. Its value depends on integration with electronic health records, mobile workflows, coordinator oversight, and transparent decision support. An AI-based home health scheduling system provides a pathway toward a more responsive and coordinated home health operations model. By combining clinical prioritization with routing, workforce matching, and follow-up risk mitigation, such a framework could support both care quality and workforce efficiency.
Healthcare quality improvement increasingly relies on routinely collected data to identify preventable harm, missed care opportunities, adverse outcomes, and variation in performance. Artificial intelligence predictive models may support earlier detection of quality risks and enable more proactive monitoring than retrospective audits alone. This systematic review examined artificial intelligence predictive models for healthcare quality improvement from 2017 to 2024. The review focused on patient safety events, care gaps, adverse clinical outcomes, and performance monitoring systems. A PRISMA 2020-compliant search was conducted across PubMed, Scopus, Web of Science, and IEEE Xplore for peer-reviewed English-language studies published from 2017 through 2024. Dual screening, structured data extraction, risk-of-bias assessment, and narrative synthesis were used. The evidence base showed growing use of machine learning for pressure injuries, sepsis, readmission, mortality, ICU transfer, and continuous monitoring. However, most studies remained retrospective model-development or validation studies, while fewer described deployment within formal quality improvement workflows. Technical progress in predictive modelling for quality improvement is substantial, but evidence of sustained improvement in care processes, safety outcomes, or organisational performance remains limited. Stronger prospective evaluation and clearer integration with improvement methods are needed.
Artificial intelligence models are increasingly used to support healthcare decision-making, resource allocation, clinical triage, population health management, and quality improvement. Without explicit equity assessment, these tools may reproduce, obscure, or scale existing disparities across racial, ethnic, sex, gender, socioeconomic, and geographic groups. This systematic review examined artificial intelligence approaches for healthcare equity analytics from 2017 to 2024. The review focused on bias detection, fairness-aware prediction, disparity monitoring, and algorithmic accountability in health systems. A PRISMA 2020-compliant search was conducted across PubMed, Scopus, Web of Science, and IEEE Xplore for peer-reviewed English-language studies published between 2017 and 2024. Eligible records were screened by two reviewers, and findings were synthesised narratively by equity task, method type, clinical application, fairness metric, and implementation context. The evidence base showed increasing attention to bias detection and fairness-aware algorithm design, especially in clinical risk prediction, diagnostic imaging, and population health management. Disparity monitoring systems and accountability structures were less frequently evaluated in deployed health system environments and were commonly described as governance recommendations, audit frameworks, or pilot-stage approaches. The technical foundations for equitable artificial intelligence in healthcare are advancing, but translation into operational health system practice remains limited. The strongest evidence concerns bias measurement, whereas evidence that fairness interventions reduce real-world health disparities remains nascent.
Preventive care delivery remains inconsistent despite well-established recommendations for cancer screening, immunization, and chronic disease monitoring. Missed preventive services create avoidable downstream morbidity, delayed diagnosis, and inefficient use of primary care resources. Current preventive care gap closure strategies are often reactive, fragmented, and dependent on manual review. Primary care clinicians cannot feasibly reconstruct every patient’s eligibility status, prior reminders, portal behavior, and visit timing during brief encounters. This article proposes an artificial intelligence system that continuously analyzes primary care records, applies screening eligibility rules, integrates reminder logs and patient portal activity, and detects upcoming visit opportunity windows. The system would surface a personalized preventive care gap list before or during clinical contact. The framework includes a rules engine for guideline-based eligibility, an engagement module that interprets reminder history and portal behavior, a visit opportunity detector, and a prioritization engine. Together, these components would rank preventive actions by clinical relevance, timing feasibility, and patient readiness. The system would transform routine primary care encounters into targeted preventive care opportunities by delivering the right recommendation at the right moment. By combining eligibility logic with engagement and visit context, it could support proactive care without relying solely on clinician memory. A proactive, AI-enhanced preventive care system could narrow the gap between evidence-based recommendations and real-world delivery. Its value would depend on transparent rule design, workflow-sensitive implementation, and careful prospective evaluation.
Quality improvement reports distill incident narratives, safety classifications, root-cause analyses, and performance metrics into actionable learning documents. However, compiling these materials remains a manual, cognitively burdensome task that can delay organizational learning after safety events. Healthcare organizations often hold rich safety data across reporting systems, RCA documents, dashboards, and governance records. Yet these inputs are rarely transformed into standardized QI reports through a single coherent workflow. This article proposes a conversational artificial intelligence assistant that engages quality officers in a structured dialogue, retrieves relevant safety-event evidence, and generates a draft QI report following a pre-specified template. The assistant is conceptualized as a human-supervised system rather than an autonomous decision-maker. The proposed assistant includes an incident narrative NLP module, safety classification aligner, RCA note retriever, performance metric trend summarizer, and template-guided large language model. These components would support structured reporting while preserving human review and organizational accountability. The assistant could shorten the time from incident review to report drafting, improve reproducibility across QI documentation, and reduce administrative burden for patient safety teams. Its value would depend on careful grounding, privacy protection, verification workflows, and user trust. Conversational AI offers a pathway toward AI-augmented safety reporting that supports, rather than replaces, human expertise. The proposed model emphasizes structured synthesis, transparent evidence use, and a learning culture in healthcare quality improvement.